According to Zimmer Biomet's latest financial reports the company's current EPS (TTM) is HK$35.56. In 2024 the company made an earnings per share (EPS) of HK$34.93 a decrease over its 2023 EPS that were of HK$38.54.
Year | EPS | Change |
---|---|---|
2025 (TTM) | HK$35.25 | 0.92% |
2024 | HK$34.93 | -9.37% |
2023 | HK$38.54 | 346.36% |
2022 | HK$8.63 | -43.01% |
2021 | HK$15.15 | -383.82% |
2020 | -HK$5.34 | -112.34% |
2019 | HK$43.25 | |
2017 | HK$71.43 | 510.74% |
2016 | HK$11.70 | |
2013 | HK$35.24 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Stryker Corporation SYK | HK$58.79 | 65.34% | ๐บ๐ธ USA |
![]() Cooper Companies COO | HK$16.29 | -54.20% | ๐บ๐ธ USA |
![]() Dentsply Sirona
XRAY | -HK$35.64 | -200.22% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | HK$55.02 | 54.75% | ๐บ๐ธ USA |